Filter
2018
Filtered Results: 2018
Text search:
pharmaceutical
management
Featured
Recommendations
195
New Publications
572
Language
Document type
No document type
1054
Studies & Reports
358
Guidelines
335
Manuals
92
Strategic & Response Plan
92
Fact sheets
32
Training Material
24
Situation Updates
13
Resource Platforms
11
Infographics
4
Brochures
2
Online Courses
1
Countries / Regions
Kenya
88
Ethiopia
83
India
81
Global
73
South Africa
53
Nigeria
46
Western and Central Europe
46
Liberia
40
Sierra Leone
38
Uganda
38
Ghana
31
Nepal
30
Rwanda
30
Tanzania
29
Namibia
29
Zambia
28
Malawi
26
Bangladesh
25
Africa
25
Ukraine
22
Latin America and the Carribbean
21
Philippines
20
Indonesia
18
Syria
17
Eastern Europe
17
Lesotho
16
Zimbabwe
15
Cambodia
15
Eswatini/ Swaziland
13
Myanmar / Burma
13
South–East Asia Region
13
Congo, Democratic Republic of
12
Botswana
11
West and Central Africa
11
Germany
9
Eastern Europe and Central Asia
9
Cameroon
8
South Sudan
8
East and Southern Africa
8
Asia
8
Russia
8
Guinea
7
Senegal
7
Brazil
7
Burkina Faso
6
Haiti
6
Thailand
6
Middle East and North Africa
5
Western Pacific Region
5
Pakistan
4
Mozambique
4
Papua New Guinea
4
Benin
4
Albania
4
Laos
4
Vietnam
4
Mali
3
USA
3
Jordan
3
Afghanistan
3
Egypt
3
China
3
Sudan
3
North Macedonia
3
Chile
3
Fiji
3
United Kingdom
3
Iraq
2
Lebanon
2
Central African Republic
2
Serbia
2
Yemen
2
Southern Africa
2
Tajikistan
2
Lithuania
2
Moldova
2
Kyrgyzstan
2
Georgia
2
North America
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Chad
1
Argentina
1
Peru
1
Bolivia
1
Libya
1
Angola
1
Sri Lanka
1
Bhutan
1
Venezuela
1
Palestine
1
Armenia
1
Timor Leste/ East Timor
1
Bulgaria
1
Romania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
857
Clinical Guidelines
136
Public Health
108
Key Resources
77
Women & Child Health
50
Pharmacy & Technologies
32
Capacity Building
15
Annual Report MEDBOX
2
Toolboxes
Pharmacy
202
AMR
191
COVID-19
149
Mental Health
106
TB
101
HIV
100
Rapid Response
61
NCDs
47
Planetary Health
46
Caregiver
42
NTDs
41
Ebola
35
Conflict
35
Global Health Education
33
Health Financing Toolbox
21
Specific Hazards
14
Disability
11
Polio
11
Natural Hazards
11
Refugee
11
Social Ethics
3
Cholera
2
Health Financing
2
South Sudan
1
Zika
1
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
The era of effective antibiotics is coming to a close. In just a few generations, many “miracle medicines”have been beaten into ineffectiveness by the bacteria they were intended to eradicate. Bacteria quickly adapt to the presence of antibacterial agents in order ...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
This paper was developed to support AMR coordination committees and others tasked with addressing AMR at country level to do just that. Drawing on the published literature and the operational experience and expertise of different LMICs, the paper points to six key strategies for success and offers a...
Версия: 2
Дата: 10 февраля 2020 г.
Протокол посвящен выявлению и отслеживанию пациентов и их близких контактов в общей массе населения либо в условиях локального рас...
NAMI HelpLine
Contents
I’m having a lot of anxiety because of the coronavirus. Please help.
I’m quarantined or working from home – lonely and isolated even further – what can I do?
I don’t have health insurance or a regular doctor – how can I get care?
What if I’m quarantin...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul...
On 31st December 2019, the World Health Organization (WHO) China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. On 7th January 2020, Chinese authorities identified a new strain of Coronavirus as the causative age...
This strategy, produced by IFRC, UNICEF and WHO, provides an overview of RCCE coordination approach and priorities across the different phases of the COVID-19 preparedness and response
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR,
infection prevention and control. It will support nurses on better action and also on communication towards
their patients and families.
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
May 2020 International Journal of Infectious Diseases 96 DOI: 10.1016/j.ijid.2020.05.003
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
This is an abridged version of the 2019 Standards containing the evidence-based recommendations most pertinent to primary care. The tables and figures have been renum-bered from the original document to match this version. The complete 2019 Standards of Care do...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release into the environment. The purpose of the document is to identify existing instruments and standards in ...
Lancet Glob Health 2020Published OnlineNovember 27, 2020 https://doi.org/10.1016/S2214-109X(20)30449-6
